Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - September 2005

  1. Preventable Measles Among U.S. Residents, 2001-2004.   MMWR Morb Mortal Wkly Rep; 54 (33): 817-820; August 26, 2005.

  2. 6th Canadian Immunization Conference. Montreal, Quebec, 5 to 8 December, 2004. Oral Scientific Abstracts.   Can Commun Dis Rep; 31 (15): 161-167; August 1, 2005.

  3. The Immunization Sentinel Site Program in Michigan.   Mich Med; 104 (4): 24; July, 2005.

  4. Tiered Use of Inactivated Influenza Vaccine in the Event of a Vaccine Shortage.   MMWR Morb Mortal Wkly Rep; 54 (30): 749-750; August 5, 2005.

  5. Adler, U. C. The Influence of Childhood Infections and Vaccination on the Development of Atopy: a Systematic Review of the Direct Epidemiological Evidence.   Homeopathy; 94 (3): 182-195; July, 2005.

  6. Agarwal, S.; Bhanot, A.; Goindi, G. Understanding and Addressing Childhood Immunization Coverage in Urban Slums.    Indian Pediatr; 42 (7): 653-663; July, 2005.

  7. Alp, H.; Altinkaynak, S.; Arikan, D.; Ozyazicioglu, N. Adolescent Immunization Rates and the Effect of Socio-Demographic Factors on Immunization in a Cosmopolitan City (ERZURUM) in the Eastern Turkey.   Health Policy; July 28, 2005. [Epub ahead of print]

  8. Arenz, S.; Schmitt, H. J.; Tischer, A.; von, Kries R. Effectiveness of Measles Vaccination After Household Exposure During a Measles Outbreak: a Household Contact Study in Coburg, Bavaria.   Pediatr Infect Dis J; 24 (8): 697-699; August, 2005.

  9. Baleta, A. African Conference Highlights Gaps in Vaccination.  Lancet Infect Dis; 5 (8): 472-473; August, 2005.

  10. Bauch, C. T. Imitation Dynamics Predict Vaccinating Behaviour.  Proc Biol Sci; 272 (1573): 1669-1675; August 22, 2005.

  11. Brownstein, J. S.; Kleinman, K. P.; Mandl, K. D. Identifying Pediatric Age Groups for Influenza Vaccination Using a Real-Time Regional Surveillance System.   Am J Epidemiol; August 17, 2005. [Epub ahead of print]

  12. Buchta, C.; Kormoczi, G.; Heinze, G.; Puhr, R.; Kompatscher, M.; Jungling, G.; List, J.; Macher, M.; Hocker, P.; Watkins-Riedel, T.; Dettke, M. Lack of Impact of ABO Blood Group or Corresponding Isoantibodies on the Immune Response After Rabies Vaccination.   Wien Klin Wochenschr; 117 (11-12): 412-416; June, 2005.

  13. Butler, D. Drugs Could Head Off a Flu Pandemic--but Only If We Respond Fast Enough.   Nature; 436 (7051): 614-615; August 4, 2005.

  14. Canning, H. S.; Phillips, J.; Allsup, S. Health Care Worker Beliefs About Influenza Vaccine and Reasons for Non-Vaccination--a Cross-Sectional Survey.   J Clin Nurs; 14 (8): 922-925; September, 2005.

  15. Cherif, H.; Landgren, O.; Konradsen, H. B.; Kalin, M.; Bjorkholm, M.  Poor Antibody Response to Pneumococcal Polysaccharide Vaccination Suggests Increased Susceptibility to Pneumococcal Infection in Splenectomized Patients With Hematological Diseases.   Vaccine; August 15, 2005. [Epub ahead of print]

  16. Cizman, M.; Pokorn, M.; Osredkar, D.  Re: Transverse Myelitis After Measles and Rubella Vaccination.   J Paediatr Child Health; 41 (8): 460; August, 2005.

  17. Davis, M. M.  Varicella Vaccine, Cost-Effectiveness Analyses, and Vaccination Policy.   JAMA; 294 (7): 845-846; August 17, 2005.

  18. Drake, M.  The Vaccination Registers: What Are They and What Can We Learn From Them?   Local Popul Stud; 74: 36-53; 2005.

  19. Enserink, M.  Avian Influenza. 'Pandemic Vaccine' Appears to Protect Only at High Doses.   Science; 309 (5737): 996; August 12, 2005.

  20. Gaudin, S.; Yazbeck, A. S.  Immunization in India 1993-1999: Wealth, Gender, and Regional Inequalities Revisited.   Soc Sci Med; August 4, 2005. [Pubmed ahead of print]

  21. Goldman, G. S.  Universal Varicella Vaccination: Efficacy Trends and Effect on Herpes Zoster.   Int J Toxicol; 24 (4): 205-213; July, 2005.

  22. Greenberg, D. P.  Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents.   Pediatr Infect Dis J; 24 (8): 721-728; August, 2005.

  23. Gupta, P.; Choudhury, P.  Meningococcemia Update Vaccination and Chemoprophylaxis.   Indian Pediatr; 42 (7): 641-644; July, 2005.

  24. Haas, D. M.; Flowers, C. A.; Congdon, C. L.  Rubella, Rubeola, and Mumps in Pregnant Women: Susceptibilities and Strategies for Testing and Vaccinating.   Obstet Gynecol; 106 (2): 295-300; August, 2005.

  25. Hammarlund, E.; Lewis, M. W.; Carter, S. V.; Amanna, I.; Hansen, S. G.; Strelow, L. I.; Wong, S. W.; Yoshihara, P.; Hanifin, J. M.; Slifka, M. K.  Multiple Diagnostic Techniques Identify Previously Vaccinated Individuals With Protective Immunity Against Monkeypox.   Nat Med; August 7, 2005. [Epub ahead of print]

  26. Harper, S. A.; Fukuda, K.; Uyeki, T. M.; Cox, N. J.; Bridges, C. B.  Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).   MMWR Recomm Rep; 54 (RR-8): 1-40; July 29, 2005.

  27. Hviid, A.; Wohlfahrt, J.; Stellfeld, M.; Melbye, M.  Childhood Vaccination and Nontargeted Infectious Disease Hospitalization.   JAMA; 294 (6): 699-705; August 10, 2005.

  28. Kim, S. H.; Yeo, S. G.; Jang, H. C.; Park, W. B.; Lee, C. S.; Lee, K. D.; Kim, H. B.; Kim, N. J.; Kim, Y. T.; Jee, Y.; Cho, H.; Oh, M. D.; Choe, K. W.  Clinical Responses to Smallpox Vaccine in Vaccinia-Naive and Previously Vaccinated Populations: Undiluted and Diluted Lancy-Vaxina Vaccine in a Single-Blind, Randomized, Prospective Trial.   J Infect Dis; 192 (6): 1066-1070; September 15, 2005.

  29. Kudva, I. T.; Griffin, R. W.; Garren, J. M.; Calderwood, S. B.; John, M.  Identification of a Protein Subset of the Anthrax Spore Immunome in Humans Immunized With the Anthrax Vaccine Adsorbed Preparation.   Infect Immun; 73 (9): 5685-5696; September, 2005.

  30. Labelle, C.; Macpherson, D. W.  Evaluation of Yellow Fever Vaccination Centers in Canada.   J Travel Med; 12 (4): 180-183; July, 2005.

  31. Lane, L.; Reynolds, A.; Ramsay, M.  When Should Vaccination Be Contraindicated in Children?   Drug Saf; 28 (9): 743-752; 2005.

  32. Longini, I. M., Jr.; Nizam, A.; Xu, S.; Ungchusak, K.; Hanshaoworakul, W.; Cummings, D. A.; Halloran, M. E.  Containing Pandemic Influenza at the Source.   Science; 309 (5737): 1083-1087; August 12, 2005.

  33. Maurer, W.  Death Following Hexavalent Vaccination.   Vaccine; August 9, 2005. [Epub ahead of print]

  34. May, S. A.; Netto, G.; Domiati-Saad, R.; Kasper, C.  Cutaneous Lymphoid Hyperplasia and Marginal Zone B-Cell Lymphoma Following Vaccination.   J Am Acad Dermatol; 53 (3): 512-516; September, 2005.

  35. Metlay, J. P.; Fishman, N. O.; Joffe, M.; Edelstein, P. H.  Impact of Pediatric Vaccination With Pneumococcal Conjugate Vaccine on the Risk of Bacteremic Pneumococcal Pneumonia in Adults.   Vaccine; August 24, 2005. [Epub ahead of print]

  36. Michel, R.; Garnotel, E.; Spiegel, A.; Morillon, M.; Saliou, P.; Boutin, J. P.  Outbreak of Typhoid Fever in Vaccinated Members of the French Armed Forces in the Ivory Coast.   Eur J Epidemiol; 20 (7): 635-642; 2005.

  37. Music, S.  Towards Universal Childhood Immunization: Why We Must and How We Might.   Vaccine; August 22, 2005. [Epub ahead of print]

  38. Oglesby, A.  Staying Healthy. Prevention Through Immunization.   Diabetes Self Manag; 22 (4): 48-50; July, 2005.

  39. Panhotra, B. R.; Saxena, A. K.  Negative Attitude of Health Care Workers Towards Childhood Vaccination Program.   Vaccine; August 23, 2005. [Epub ahead of print]

  40. Podewils, L. J.; Antil, L.; Hummelman, E.; Bresee, J.; Parashar, U. D.; Rheingans, R.  Projected Cost-Effectiveness of Rotavirus Vaccination for Children in Asia.   J Infect Dis; 192 Suppl 1:S133-45; September 1, 2005.

  41. Rosenthal, S. L.  Protecting Their Adolescents From Harm: Parental Views on STI Vaccination.   J Adolesc Health; 37 (3): 177-178; September, 2005.

  42. Rota, M. C.; D'Ancona, F.; Massari, M.; Mandolini, D.; Giammanco, A.; Carbonari, P.; Salmaso, S.; Atti, M. L.  How Increased Pertussis Vaccination Coverage Is Changing the Epidemiology of Pertussis in Italy.   Vaccine; August 17, 2005. [Epub ahead of print]

  43. Santos, A. P.; Bertho, A. L.; Dias, D. C.; Santos, J. R.; Marcovistz, R.  Lymphocyte Subset Analyses in Healthy Adults Vaccinated With Yellow Fever 17DD Virus.   Mem Inst Oswaldo Cruz; 100 (3): 331-337; May, 2005.

  44. Schmitt, H. J.; Siegrist, C. A.; Salmaso, S.; Law, B.; Booy, R.  B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination.   Vaccine; August 3, 2005. [Epub ahead of print]

  45. Simonsen, L.; Viboud, C.; Elixhauser, A.; Taylor, R. J.; Kapikian, A. Z.  More on RotaShield and Intussusception: The Role of Age at the Time of Vaccination.   J Infect Dis; 192 Suppl 1:S36-43; September 1, 2005.

  46. Soleimanjahi, H.; Bamdad, T.; Fotouhi, F.; Roustai, M. H.; Faghihzadeh, S.  Prevalence of HI Antibody Titer Against Rubella Virus to Determine the Effect of Mass Vaccination in Tehran.   J Clin Virol; July 30, 2005. [Epub ahead of print]

  47. Solomon, A. W.; Mabey, D. C.  Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydiatrachomatis.   Vaccine; August 22, 2005. [Epub ahead of print]

  48. Southern, J.; Crowley-Luke, A.; Borrow, R.; Andrews, N.; Miller, E.  Immunogenicity of One, Two or Three Doses of a Meningococcal C Conjugate Vaccine Conjugated to Tetanus Toxoid, Given As a Three-Dose Primary Vaccination Course in UK Infants at 2, 3 and 4 Months of Age With Acellular Pertussis-Containing DTP/Hib Vaccine.   Vaccine; August 17, 2005. [Epub ahead of print]

  49. Tabbarah, M.; Zimmerman, R. K.; Nowalk, M. P.; Janosky, J. E.; Troy, J. A.; Raymund, M.; Jewell, I. K.  What Predicts Influenza Vaccination Status in Older Americans Over Several Years?   J Am Geriatr Soc; 53 (8): 1354-1359; August, 2005.

  50. Vellozzi, C.; Lane, J. M.; Averhoff, F.; Maurer, T.; Norton, S.; Damon, I.; Casey, C.  Generalized Vaccinia, Progressive Vaccinia, and Eczema Vaccinatum Are Rare Following Smallpox (Vaccinia) Vaccination: United States Surveillance, 2003.   Clin Infect Dis; 41 (5): 689-697; September 1, 2005.

  51. von, Kries R.  Comment on B. Zinka Et Al., Unexplained Cases of Sudden Infant Death Shortly After Hexavalent Vaccination.   Vaccine; August 1, 2005. [Epub ahead of print]

  52. Weir, E.  Vaccination Boosts Adult Immunity to Varicella Zoster Virus.   CMAJ; 173 (3): 249; August 2, 2005.

  53. Wood, N.; Menzies, R.; McIntyre, P.  Epiglottitis in Sydney Before and After the Introduction of Vaccination Against Haemophilus Influenzae Type b Disease.   Intern Med J; 35 (9): 530-535; September, 2005.

  54. Wuorimaa, T. K.; Dagan, R.; Bailleux, F.; Haikala, R.; Ekstrom, N.; Eskola, J.; Yaich, M.; Kayhty, H.  Functional Activity of Antibodies After Immunization of Finnish and Israeli Infants With an 11-Valent Pneumococcal Conjugate Vaccine.   Vaccine; August, 2005. [Epub ahead of print]

  55. Zhou, F.; Harpaz, R.; Jumaan, A. O.; Winston, C. A.; Shefer, A.  Impact of Varicella Vaccination on Health Care Utilization.   JAMA; 294 (7): 797-802; August 17, 2005.

Back to Top